梦想综合体在癌症和治疗机会中的新兴作用
Ye-Jin Hwang1,2, Moon Jong Kim1,2
1Department of Life Science, Gachon University, Seongnam 13120, Republic of Korea.
International journal of molecular sciences
|January 11, 2025
概括
梦想复合体调节细胞周期和静止状态. 了解它在癌症中的作用和开发向疗法可以提供新的治疗选择.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- DREAM复合体 (二分化伙伴,RB类,E2F和多类B类) 是一个保存的转录抑制剂.
- 它通过控制大约一千个点基因来调节细胞循环的进展,并诱导细胞静止.
- 细胞周期的失调是癌症的标志,使得DREAM复合体成为瘤发生的潜在因素.
研究的目的:
- 审查当前对DREAM复合体在癌症中的作用的理解.
- 为了确定受DREAM复杂变化的影响的特定癌症类型.
- 探索针对DREAM复合体进行癌症治疗的治疗策略.
主要方法:
- 对DREAM复杂性研究近期进展的文献综述.
- 分析DREAM复合体在细胞循环调节和癌症中的作用.
- 探索针对DREAM复合体的潜在治疗干预措施.
主要成果:
- 梦想复合体在细胞周期控制和静止中发挥着重要作用.
- 它对各种癌症类型的参与是一个正在积极研究的领域.
- 针对DREAM复合体提供了一个潜在的,但尚未探索的治疗途径.
结论:
- 对DREAM复合体在不同癌症中的特定作用进行进一步的研究是有必要的.
- 开发针对DREAM复合体的疗法可能会提供新的癌症治疗策略.
- 了解DREAM复合体对于推进癌症疗法至关重要.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
08:26MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
Published on: February 17, 2012
14.5K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
